An insight into current diabetes therapeutics,
hot topics and management challenges
Overview

Due to the widespread complications associated with type 2 diabetes, a number of guidelines may be consulted when treating patients. Whilst guidelines may not always be favoured by physicians and some could be considered confusing, it is important to focus on the person presenting with diabetes to ensure that they receive optimal care. At this meeting, speakers will share their insights and recommendations. Delegates will also have the opportunity to strengthen their interviewing skills by participating in a motivational interviewing workshop.

This is a promotional meeting organised and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance.
Omnia-Med is providing logistical support.
Boehringer Ingelheim and Lilly Diabetes Alliance products will be discussed at this meeting.

Click here to access prescribing information

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone) (UK only).

Forthcoming Meetings

UK/DIA/00265f(1) Date of Preparation September 2015